The U.S. Judicial Panel on Multidistrict Litigation has centralized all federally filed Propecia lawsuits to the U.S. District Court for the Eastern District of New York under U.S. District Judge John Gleeson for pre-trial proceedings.
The Multidistrict Litigation, or MDL, consolidates nine lawsuits, which are currently pending in six federal courts, though legal experts believe the MDL will grow as more lawsuits are filed once Merck updates the warning label of the hair loss medication Propecia to include the potential risk of permanent sexual dysfunction.
Previously, the warning label of Propecia sold in the US included the warning that potential side effects, including sexual dysfunction, subside once the medication is discontinued. The warning label in some other countries however warned that some side effects, including sexual dysfunction could be permanent.
The current consolidated lawsuits allege that Merck failed to adequately warn physicians and consumers that Propecia could potentially cause long-term or permanent side effects, including loss of libido, erectile dysfunction, impotence, loss of fertility, and depression.
Last month, the New Jersey Supreme Court centralized Propecia lawsuits filed at the state level under Superior Court Judge Jessica R. Mayer however, the litigation was not designated as a mass tort.